Johanna Holldack
Director/Board Member at PHOTOCURE ASA
Net worth: - $ as of 2024-03-30
Profile
Johanna Holldack is the founder and CEO of Kupando GmbH, which was founded in 2018.
She is currently the Chairman of Amal Therapeutics SA and an Independent Director at Photocure ASA since 2017.
Dr. Holldack's former positions include being the CEO of Borean Pharma ApS, Telormedix SA, and MediGene AG.
She was also a Partner at Aravis AG from 2009 to 2013, an Assistant Professor at the University of Duisburg-Essen, a Research Associate at Harvard Medical School, and a Member of Deutsche Krebshilfe gGmbH.
Dr. Holldack received her undergraduate and doctorate degrees from the University of Gottingen.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PHOTOCURE ASA
-.--% | 2022-12-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Johanna Holldack active positions
Companies | Position | Start |
---|---|---|
PHOTOCURE ASA | Director/Board Member | 2017-04-27 |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Chairman | - |
Kupando GmbH
Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Chief Executive Officer | 2018-03-28 |
Former positions of Johanna Holldack
Companies | Position | End |
---|---|---|
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Private Equity Investor | 2013-12-30 |
Borean Pharma ApS
Borean Pharma ApS Pharmaceuticals: MajorHealth Technology Borean Pharma ApS provides biopharmaceuticals drugs and protein engineering services. Its two main components of technology platform are CTLD library technology and trimerisation technology. The company was founded by Hans Christian Thøgersen and Michael Etzerodt in 1997 and is located in Aarhus, Denmark. | Chief Executive Officer | 2008-04-15 |
Deutsche Krebshilfe gGmbH
Deutsche Krebshilfe gGmbH Miscellaneous Commercial ServicesCommercial Services Deutsche Krebshilfe gGmbH is a non-profit organization that fights against cancer by supporting various projects through donations. The non-profit company is based in Bonn, Germany and was founded in 1974 by Mildred Scheel. The German company provides information on funding projects, the origin and use of funds, and other relevant data in their annual report. The company encourages people to donate to their cause and provide answers to frequently asked questions about donations. The CEO is Gerd Nettekoven. | Corporate Officer/Principal | - |
Harvard Medical School | Corporate Officer/Principal | - |
University of Duisburg-Essen | Corporate Officer/Principal | - |
Training of Johanna Holldack
University of Gottingen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PHOTOCURE ASA | Health Technology |
MEDIGENE AG | Health Technology |
Private companies | 6 |
---|---|
Borean Pharma ApS
Borean Pharma ApS Pharmaceuticals: MajorHealth Technology Borean Pharma ApS provides biopharmaceuticals drugs and protein engineering services. Its two main components of technology platform are CTLD library technology and trimerisation technology. The company was founded by Hans Christian Thøgersen and Michael Etzerodt in 1997 and is located in Aarhus, Denmark. | Health Technology |
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Finance |
Telormedix SA
Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Health Technology |
Deutsche Krebshilfe gGmbH
Deutsche Krebshilfe gGmbH Miscellaneous Commercial ServicesCommercial Services Deutsche Krebshilfe gGmbH is a non-profit organization that fights against cancer by supporting various projects through donations. The non-profit company is based in Bonn, Germany and was founded in 1974 by Mildred Scheel. The German company provides information on funding projects, the origin and use of funds, and other relevant data in their annual report. The company encourages people to donate to their cause and provide answers to frequently asked questions about donations. The CEO is Gerd Nettekoven. | Commercial Services |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Health Technology |
Kupando GmbH
Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Health Technology |
- Stock Market
- Insiders
- Johanna Holldack